S130: PRELIMINARY RESULTS OF QUIWI: A DOUBLE BLINDED, RANDOMIZED CLINICAL TRIAL COMPARING STANDARD CHEMOTHERAPY PLUS QUIZARTINIB VERSUS PLACEBO IN ADULT PATIENTS WITH NEWLY DIAGNOSED FLT3-ITD WILD-TYPE AMLPau Montesinos, Jorge Labrador, Carmen Botella et al.|HemaSphere|2023Cited by 14
PB1781: THE APPLICATION OF CF-DNA FOR NGS MRD STUDIES IN PATIENTS WITH LMA IMPROVES THE SENSITIVITY OF THE METHOD WITH RESPECT TO CTC.Noemí Álvarez Sánchez-Redondo, Rosa Ayala, Alejandro Martı́n et al.|HemaSphere|2023Cited by 0